| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |